Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,059 | 727,404 | 161,037 | 508,663 | 501,217 |
| Marketable Securities | 806,093 | 376,911 | 284,594 | 52,961 | 91,190 |
| Receivables | 1,824 | 3,083 | 5,086 | 1,329 | 2,334 |
| TOTAL | $1,028,754 | $1,125,918 | $460,725 | $572,477 | $601,280 |
| Non-Current Assets | |||||
| PPE Net | 23,493 | 23,445 | 23,114 | 27,836 | 28,756 |
| Investments And Advances | 215,762 | 165,354 | 82,412 | 0 | 0 |
| Other Non-Current Assets | 16,526 | 15,336 | 120,652 | 9,721 | 7,524 |
| TOTAL | $255,781 | $204,135 | $226,178 | $37,557 | $36,280 |
| Total Assets | $1,284,535 | $1,330,053 | $686,903 | $610,034 | $637,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,038 | 20,148 | 16,181 | 7,975 | 6,855 |
| Accrued Expenses | 11,599 | 8,151 | 10,454 | 9,793 | 9,668 |
| TOTAL | $28,178 | $31,709 | $29,918 | $21,952 | $20,917 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 800 | 800 |
| Other Non-Current Liabilities | 7,770 | 6,368 | 1,301 | 1,019 | 1,011 |
| TOTAL | $55,368 | $54,907 | $50,727 | $56,766 | $57,805 |
| Total Liabilities | $83,546 | $86,616 | $80,645 | $78,718 | $78,722 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,825 | 49,570 | 49,463 | 49,406 | 49,348 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -941,821 | -880,418 | -1,500,552 | -1,569,263 | -1,534,948 |
| Other shareholders' equity | 1,307 | 502 | -155 | -20 | -177 |
| TOTAL | $1,200,989 | $1,243,437 | $606,258 | $531,316 | $558,838 |
| Total Liabilities And Equity | $1,284,535 | $1,330,053 | $686,903 | $610,034 | $637,560 |